287 related articles for article (PubMed ID: 19712701)
21. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of ganciclovir-resistant cytomegalovirus].
Eizuru Y
Nihon Rinsho; 1998 Jan; 56(1):151-5. PubMed ID: 9465681
[TBL] [Abstract][Full Text] [Related]
23. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system.
Baldanti F; Michel D; Simoncini L; Heuschmid M; Zimmermann A; Minisini R; Schaarschmidt P; Schmid T; Gerna G; Mertens T
Antiviral Res; 2002 Apr; 54(1):59-67. PubMed ID: 11888658
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
[TBL] [Abstract][Full Text] [Related]
26. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144
[TBL] [Abstract][Full Text] [Related]
27. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.
Sullivan V; Talarico CL; Stanat SC; Davis M; Coen DM; Biron KK
Nature; 1992 Jul; 358(6382):162-4. PubMed ID: 1319560
[TBL] [Abstract][Full Text] [Related]
28. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
29. [Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene].
Oyarzún MA; Bustos P; González M; Domínguez MI; Aguayo F; Nervi B; Ferres M
Rev Med Chil; 2010 Apr; 138(4):421-7. PubMed ID: 20668789
[TBL] [Abstract][Full Text] [Related]
30. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan.
Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM
J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665
[TBL] [Abstract][Full Text] [Related]
31. A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.
Zhang Y; Zhao Z; Sun J; Cao G; Zhao F; Hu J; Liu L; Ji Y
Arch Virol; 2013 Jan; 158(1):247-50. PubMed ID: 23011309
[TBL] [Abstract][Full Text] [Related]
32. Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.
Boutolleau D; Burrel S; Agut H
Antiviral Res; 2011 Jul; 91(1):32-5. PubMed ID: 21570426
[TBL] [Abstract][Full Text] [Related]
33. [Drug susceptibility and UL97 gene mutation analysis of cytomegalovirus in recipients of hematopoietic stem cell transplantation].
Zeng A; Dong D; Cui X; Guo M; Zou D; Fang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):519-22. PubMed ID: 24752100
[TBL] [Abstract][Full Text] [Related]
34. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
[TBL] [Abstract][Full Text] [Related]
35. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.
Talarico CL; Burnette TC; Miller WH; Smith SL; Davis MG; Stanat SC; Ng TI; He Z; Coen DM; Roizman B; Biron KK
Antimicrob Agents Chemother; 1999 Aug; 43(8):1941-6. PubMed ID: 10428917
[TBL] [Abstract][Full Text] [Related]
36. Genotyping cytomegalovirus UL97 mutations by high-resolution melting analysis with unlabeled probe.
Zhao XT; Zhou DQ; Wu S; Chen YW; Shao Y; Zhang J; Xia CS; Wang KP; Yang H; Wan J; Yu B; Zhang Z; Zhang W
Arch Virol; 2012 Mar; 157(3):475-81. PubMed ID: 22205145
[TBL] [Abstract][Full Text] [Related]
37. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.
Zhou L; Harder TC; Ullmann U; Rautenberg P
J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892
[TBL] [Abstract][Full Text] [Related]
38. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase.
Safronetz D; Petric M; Tellier R; Parvez B; Tipples GA
J Med Virol; 2003 Nov; 71(3):434-9. PubMed ID: 12966551
[TBL] [Abstract][Full Text] [Related]
39. Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients.
Benzi F; Vanni I; Cassina G; Ugolotti E; Di Marco E; Cirillo C; Cristina E; Morreale G; Melioli G; Malnati M; Biassoni R
J Clin Virol; 2012 May; 54(1):48-55. PubMed ID: 22300656
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China.
Zhou L; Fan J; Zheng SS; Ma WH
Transplant Proc; 2006 Nov; 38(9):2926-8. PubMed ID: 17112867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
